Single-Cell Center Würzburg: Website just launched
To introduce the work of the new Single-Cell Center, HIRI has created a website that can be found at www.single-cell-center.de.
Würzburg, April 20, 2022 – With its core technology, single-cell analysis, the Würzburg Helmholtz Institute for RNA-based Infection Research (HIRI) is a pioneer in the field of personalized medicine. In order to consistently develop this promising field of research, HIRI established the Single-Cell Center Würzburg last year together with local partners. Thanks to seed funding from the Bavarian State Ministry of Economic Affairs, Regional Development and Energy, the center aims to pool scientific, clinical and methodological expertise relevant to innovative single-cell research at the site.
To accompany this, HIRI has now created an Internet presence for the new Single-Cell Center. The website, which can be found at www.single-cell-center.de, provides a clear explanation of single-cell analysis technology. In addition to a 3D animation, the pages offer a comprehensible insight into the research field and present the players involved. Scientists can find important publications, contacts and further resources, for example on sequencing equipment. In the future, further information will successively expand the online presentation and current projects will be introduced.
About the Single-Cell Center Würzburg
The Single-Cell Center Würzburg is a joint competence center of the Helmholtz Institute for RNA-based Infection Research (HIRI) with the Faculty of Medicine of the Julius-Maximilians-Universität (JMU), the University Hospital Würzburg (UKW), the Fraunhofer Translational Center for Regenerative Therapies (TLZ-RT), and the Max Planck Research Group at the Würzburg Institute of Systems Immunology (WüSI). Spokesperson of the Single-Cell Center is Prof Jörg Vogel, the Managing Director of the HIRI.
The center’s objective is to analyze and understand diseases at the level of individual cells. In the future, this will enable the earliest possible and most reliable prediction of a disease and how it can be treated in the best possible way.
Starting from infection research, the Würzburg Single-Cell Center will also investigate cancer, neurodegenerative disorders or cardiovascular diseases at the single cell level. The broad method spectrum of RNA sequencing technologies is to be rapidly enhanced in this context.
The Single-Cell Center is funded by the Bavarian State Ministry of Economic Affairs, Regional Development and Energy. Its goal is to pool scientific, clinical and methodological expertise in Würzburg. In the medium run, the competence center is intended to develop into a strong service unit with the participation of the JMU and the UKW.